Get Live Data
Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Syncona Share Price
  4. Syncona Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksSyncona Share News (SYNC)

Syncona Information

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.40
Bid: 110.40
Ask: 111.20
Change: 0.40 (0.36%)
Spread: 0.80 (0.725%)
Open: 110.00
High: 111.20
Low: 110.00
Prev. Close: 110.00
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 09th Jun 2022 15:55

Friday 10 June 
Industrials REIT LtdFull Year Results
Monday 13 June 
Augmentum Fintech PLCFull Year Results
Molten Ventures PLCFull Year Results
Sirius Real Estate LtdFull Year Results
Tuesday 14 June 
Ashtead Group PLCFull Year Results
Bellway PLCTrading Statement
CML Microsystems PLCFull Year Results
Crest Nicholson Holdings PLCHalf Year Results
discoverIE Group PLCFull Year Results
Driver Group PLCHalf Year Results
Ferguson PLCQ3 Results
FirstGroup PLCFull Year Results
iomart Group PLCFull Year Results
LoopUp Group PLCTrading Statement
Montanaro UK Smaller Cos Investment Trust PLCFull Year Results
OnTheMarket PLCFull Year Results
Oxford Instruments PLCFull Year Results
Paragon Banking Group PLCHalf Year Results
Renalytix PLCTrading Statement
Vianet Group PLCFull Year Results
Wednesday 15 June 
AO World PLCFull Year Results
Bloomsbury Publishing PLCFull Year Results
Castings PLCFull Year Results
Custodian REIT PLCFull Year Results
Allied Minds PLCFull Year Results
Tatton Asset Management PLCFull Year Results
FireAngel Safety Technology Group PLCTrading Statement
Idox PLCHalf Year Results
IGas Energy PLCTrading Statement
JPMorgan European Discovery Trust PLCFull Year Results
Motorpoint Group PLCFull Year Results
SCS Group PLCTrading Statement
Severfield PLCFull Year Results
WH Smith PLCQ3 Trading Update
Whitbread PLCTrading Statement
Thursday 16 June 
Best of the Best PLCFull Year Results
boohoo Group PLCTrading Statement
CareTech Holdings PLCHalf Year Results
Filtronic PLCTrading Statement
GB Group PLCFull Year Results
Halfords Group PLCFull Year Results
Halma PLCFull Year Results
JLEN Environmental Assets Group LtdFull Year Results
Lindsell Train Investment Trust PLCFull Year Results
Momentum Multi-Asset Value Trust PLCFull Year Results
Mountview Estates PLCFull Year Results
N Brown Group PLCTrading Statement
NextEnergy Solar Fund LtdFull Year Results
River & Mercantile UK Micro Cap Investment Co LtdHalf Year Results
S4 Capital PLCTrading Statement
Syncona LtdFull Year Results
Volex PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
5 Feb 2021 08:20

Syncona Investee Achilles Reports Positive Trial Review, Mulling IPO

Syncona Investee Achilles Reports Positive Trial Review, Mulling IPO

Read more
5 Feb 2021 08:01

Syncona investment Achilles upbeat on safety review of trials

(Sharecast News) - Healthcare investor Syncona said on Friday that its portfolio company Achilles Therapeutics, which is developing precision T-cell therapies to treat solid tumours, had announced that an independent data and safety monitoring committee had completed the first review of the ongoing, first-in-human phase 1 and 2 'CHIRON' and 'THETIS' trials.

Read more
6 Jan 2021 09:30

Syncona Investee Autolus To Focus On Adult Leukemia Programme in 2021

Syncona Investee Autolus To Focus On Adult Leukemia Programme in 2021

Read more
6 Jan 2021 08:36

Syncona upbeat on developments at Autolus

(Sharecast News) - Life science investor Syncona updated the market on its portfolio company Autolus on Wednesday, announcing that it would prioritise the development of the 'AUTO1' programme for adult acute lymphoblastic leukemia (ALL), based on the positive data generated in its phase 1 and 2 studies to date and a high unmet medical need.

Read more
21 Dec 2020 15:43

UK EXECUTIVE CHANGE SUMMARY: Ferguson Taps Former Ashtead, Bunzl Execs

UK EXECUTIVE CHANGE SUMMARY: Ferguson Taps Former Ashtead, Bunzl Execs

Read more
19 Nov 2020 10:12

Syncona Portfolio Companies Boost Interim Result; Launches New Company

Syncona Portfolio Companies Boost Interim Result; Launches New Company

Read more
19 Nov 2020 08:16

Syncona reports improved performance for past six months as clinical trials resume

(Sharecast News) - Healthcare company Syncona reported a "robust" performance for the six months up to 30 September in which its net assets reached a value of £1,366.7m at 203,4p per share and a net asset value total return of 9.6% in the period.

Read more
12 Nov 2020 15:55

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
2 Nov 2020 16:54

UK EXECUTIVE CHANGE SUMMARY: Kakuzi Acts To Prevent Human Rights Abuse

UK EXECUTIVE CHANGE SUMMARY: Kakuzi Acts To Prevent Human Rights Abuse

Read more
30 Oct 2020 10:06

Syncona Investee Freeline Posts Widened Interim Loss On Higher Costs

Syncona Investee Freeline Posts Widened Interim Loss On Higher Costs

Read more
30 Oct 2020 09:21

Syncona portfolio company sees interim losses widen

(Sharecast News) - Healthcare investment firm Syncona said on Friday that portfolio business Freeline Therapeutics had seen interim losses widen as a result of increased research and development costs.

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
10 Aug 2020 09:19

Syncona Life Science Portfolio Boosted By Autolus And Freeline

Syncona Life Science Portfolio Boosted By Autolus And Freeline

Read more
7 Aug 2020 09:44

Syncona Investee Freeline Therapeutics Prices IPO In New York

Syncona Investee Freeline Therapeutics Prices IPO In New York

Read more
7 Aug 2020 08:17

Syncona portfolio company Freeline prices US IPO

(Sharecast News) - Healthcare investment company Syncona announced on Friday that its portfolio company Freeline Therapeutics has priced its initial public offering in the United States.

Read more
67891011121314

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.